NR1H4 and metabolic dysfunction-associated steatohepatitis: The FXR controls several pathways involved in the pathogenesis of MASH, postulated to be independent of, and complementary to, THRβ agonism, including bile acid synthesis and circulation, lipid and glucose metabolism, inflammation, fibrosis and gut barrier integrity22,41.